|
2024
|
Invention
|
Composition and methods of use of novel phenylalanine small organic compounds to directly modulat... |
|
2023
|
Invention
|
Method to treat lipid dysregulation by modulating activity of proprotein convertase subtilisin/ke... |
|
2021
|
Invention
|
Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type ... |
|
|
Invention
|
Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (pcsk9) modulators and their use. ... |
|
2020
|
Invention
|
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9). The presen... |
|
|
Invention
|
Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate pcs... |
|
|
Invention
|
Phenylalanine small organic compounds to directly modulate pcsk9 protein activity. This invention... |
|
|
Invention
|
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9).
The prese... |
|
|
Invention
|
Compounds for binding proprotein convertase subtilisin/kexin type 9. The present disclosure relat... |
|
2018
|
Invention
|
Composition and methods of use of small molecules as binding ligands for the modulation of propro... |
|
2017
|
Invention
|
Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9).
The present disclos... |
|
2015
|
Invention
|
Proprotein convertase subtilisin kexin type 9 (pcsk9) allosteric binding ligands to modulate seru... |
|
2014
|
Invention
|
Proprotein convertase subtilisin/kexin type 9 (pcsk9) allosteric binding ligands to modulate seru... |
|
|
Invention
|
Proprotein convertase subtilisin/kexin type 9 allosteric binding ligands to modulate serum low de... |
